Back to search

Article

Ruscogenin alleviates intestinal bleeding and blood flow induced by Dasatinib through ROCK/MLC pathway

2021-08-12

Abstract excerpt

<title>Abstract</title> <p>As a second-generation broad-spectrum tyrosine kinase inhibitor, Dasatinib has the antitumor effect of inhibiting tyrosine kinases such as BCR-ABL and SRC. It is mainly used to treat chronic and acute patients with chronic myelogenous leukemia. However, Dasatinib has many side effects, including gastrointestinal bleeding, respiratory infections, and renal failure, and effective means to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4f2f6b43-cbe1-5aaa-8012-29b4054ba21f
DOI
10.21203/rs.3.rs-207273/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Select a neighboring publication to make it the new centre.